Immunization with hepatitis B (HBV) vaccine is recommended for all HIV-infected individuals without immunity to HBV. This patient population, however, has relatively poor HBV vaccine responses. Factors associated with this impaired HBV vaccine response in HIV-infected individuals may include older age, uncontrolled HIV replication, and low nadir CD4 cell count. Postvaccination testing for HBV surface antibody is recommended and vaccine non-responders should undergo repeat immunization with a full series. The benefit of double dosage, the appropriate strategy for HIV-infected patients with isolated HBV core antibody and the timing and number of vaccinations in persons with advanced immunosuppression on highly active antiretroviral therapy remain controversial areas.
KellermanSE, HansonDL, McNaghtenAD, FlemingPL. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis2003;188:571–7
2.
GilsonRJ, HawkinsAE, BeechamMR, Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS1997;11:597–606
3.
HadlerSC, JudsonFN, O'MalleyPM, Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis1991;163:454–9
4.
ColinJF, Cazals-HatemD, LoriotMA, Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology1999;29:1306–10
5.
ThioCL, SeabergEC, SkolaskyRJr., HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet2002;360:1921–6
6.
MastEE, WeinbaumCM, FioreAE, A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep.8 December2006;55:1–33; quiz CE31–34
7.
TedaldiEM, BakerRK, MoormanAC, Hepatitis A and B vaccination practices for ambulatory patients infected with HIV. Clin Infect Dis2004;38:1478–84
8.
DienstagJL, WernerBG, PolkBF, Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy. Ann Intern Med1984;101:34–40
9.
SzmunessW, StevensCE, HarleyEJ, Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection. N Engl J Med1982;307:1481–6
10.
CollierAC, CoreyL, MurphyVL, HandsfieldHH. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med1988;109:101–5
11.
PasrichaN, DattaU, ChawlaY, Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine. BMC Infect Dis2006;6:65
12.
VeigaAP, CassebJ, DuarteAJ. Humoral response to hepatitis B vaccination and its relationship with T CD45RA+ (naive) and CD45RO+ (memory) subsets in HIV-1-infected subjects. Vaccine2006;24:7124–8
13.
HadlerSC, FrancisDP, MaynardJE, Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med1986;315:209–14
14.
KimHN, HarringtonRD, Van RompaeyS, KitahataMM. Independent clinical predictors of hepatitis B vaccination in HIV-infected patients. Int J STD AIDS2008;19:600–4
15.
Lao-arayaM, PuthanakitT, AurpibulL, SirisanthanaT, SirisanthanaV. Antibody response to hepatitis B re-vaccination in HIV-infected children with immune recovery on highly active antiretroviral therapy. Vaccine2007;25:5324–9
16.
OvertonET, SungkanuparphS, PowderlyWG, SeyfriedW, GrogerRK, AbergJA. Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons. Clin Infect Dis2005;41:1045–8
17.
PaitoonpongL, SuankratayC. Immunological response to hepatitis B vaccination in patients with AIDS and virological response to highly active antiretroviral therapy. Scand J Infect Dis2008;40:54–8
18.
UngulkraiwitP, JongjirawisanY, AtamasirikulK, SungkanuparphS. Factors for predicting successful immune response to hepatitis B vaccination in HIV-1 infected patients. Southeast Asian J Trop Med Public Health2007;38:680–5
19.
WilsonCM, EllenbergJH, SawyerMK, Serologic response to hepatitis B vaccine in HIV infected and high-risk HIV uninfected adolescents in the REACH cohort. Reaching for Excellence in Adolescent Care and Health. J Adolesc Health2001;29:123–9
20.
de Vries-SluijsTEMS, HansenBE, van DoornumGJJ, A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients. J Infect Dis2008;197:292–4
21.
FismanDN, AgrawalD, LederK. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis2002;35:1368–75
22.
FonsecaMO, PangLW, de Paula CavalheiroN, BaroneAA, Heloisa LopesM. Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose. Vaccine2005;23:2902–8
23.
Cornejo-JuarezP, Volkow-FernandezP, Escobedo-LopezK, Vilar-CompteD, Ruiz-PalaciosG, Soto-RamirezLE. Randomized controlled trial of Hepatitis B virus vaccine in HIV-1-infected patients comparing two different doses. AIDS Res Ther2006;3:9
24.
WongEK, BodsworthNJ, SladeMA, MulhallBP, DonovanB. Response to hepatitis B vaccination in a primary care setting: influence of HIV infection, CD4+ lymphocyte count and vaccination schedule. Int J STD AIDS1996;7:490–4
25.
LandrumML, HullsiekKH, GanesanA, Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals. AIDS2009; Epub ahead of print
26.
BaileyCL, SmithV, SandsM. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults. Int J Infect Dis2008;12:e77–e83
27.
ChoyBY, PeirisJS, ChanTM, LoSK, LuiSL, LaiKN. Immunogenicity of intradermal hepatitis B vaccination in renal transplant recipients. Am J Transpl2002;2:965–9
28.
PlayfordEG, HoganPG, BansalAS, Intradermal recombinant hepatitis B vaccine for healthcare workers who fail to respond to intramuscular vaccine. Infect Control Hosp Epidemiol2002;23:87–90
29.
LevitzRE, CooperBW, ReganHC. Immunization with high-dose intradermal recombinant hepatitis B vaccine in healthcare workers who failed to respond to intramuscular vaccination. Infect Control Hosp Epidemiol1995;16:88–91
30.
ShafranSD, MashinterLD, LindemulderA, TaylorGD, ChiuI. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine. HIV Med2007;8:295–9
31.
ReyD, KrantzV, PartisaniM, Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load. Vaccine2000;18:1161–5
32.
CrucianiM, MengoliC, SerpelloniG, Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients. Vaccine2009;27:17–22
33.
BloomA, JacksonK, KiviatA, ZhengH, SaxP, GandhiR. Repeat Hepatitis B vaccination may lead to seroprotection in HIV-infected patients who do not respond to an initial series. J Acquir Immune Defic Syndr2009;50:110–3
34.
SasakiMG, FoccaciaR, de Messias-ReasonIJ. Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection. Vaccine2003;21:4545–9
35.
OvertonET, KangM, UmblejaT, ACTG 5220: Hepatitis B Vaccine Responses in HIV-infected Persons Using Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF). Paper presented at: ICAAC/IDSA, 2008
36.
CooperCL, AngelJB, SeguinI, DavisHL, CameronDW. CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years. Clin Infect Dis2008;46:1310–4
37.
CheesemanSH, DavaroRE, EllisonRT3rd. Hepatitis B vaccination and plasma HIV-1 RNA. N Engl J Med1996;334:1272
38.
ShengW-H, KaoJ-H, ChenP-J, Evolution of Hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis2007;45:1221–9
39.
ZanettiAR, MarianoA, RomanoL, Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet2005;366:1379–84
40.
Adult Prevention and Treatment of Opportunistic Infections Guidelines Working Group. Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents. 18 June 2008; available at: http://aidsinfo.nih.gov/contentfiles/Adult_OI.pdf (last accessed 11 November 2008)
41.
Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2009. Ann Intern Med2009;150:40–4
42.
ShireNJ, RousterSD, RajicicN, ShermanKE. Occult hepatitis B in HIV-infected patients. J Acquir Immune Defic Syndr2004;36:869–75
43.
FilippiniP, CoppolaN, PisapiaR, Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy. AIDS2006;20:1253–60
44.
TsuiJI, FrenchAL, SeabergEC, Prevalence and long-term effects of occult Hepatitis B virus infection in HIV-infected women. Clin Infect Dis2007;45:736–40
45.
GrobP, JilgW, BornhakH, Serological pattern ‘anti-HBc alone’: report on a workshop. J Med Virol2000;62:450–5
46.
UralO, FindikD. The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine. J InfectOct2001;43:187–90
47.
LokAS, LaiCL, WuPC. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology1988;8:766–70
48.
McMahonBJ, ParkinsonAJ, HelminiakC, Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen. Gastroenterology1992;103:590–4
49.
GandhiRT, WurcelA, LeeH, Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies. J Infect Dis2005;191:1435–41
50.
JongjirawisanY, UngulkraiwitP, SungkanuparphS. Isolated antibody to hepatitis B core antigen in HIV-1 infected patients and a pilot study of vaccination to determine the anamnestic response. J Med Assoc Thai2006;89:2028–34
51.
Advisory Committee on Immunization Practices. Recommended Adult Immunization Schedule: United States, October 2007–September 2008. Ann Intern Med2007;147(10):725–9
52.
Al-MekhaizeemKA, MirielloM, SherkerAH. The frequency and significance of isolated hepatitis B core antibody and the suggested management of patients. CMAJ2001;165:1063–4
